Dimensional Fund Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-98,129
| Closed | -$1.91M | – | 3541 |
|
|
2022
Q1 | $1.91M | Sell |
98,129
-33,532
| -25% | -$654K | ﹤0.01% | 2847 |
|
|
2021
Q4 | $2.15M | Buy |
131,661
+8,801
| +7% | +$144K | ﹤0.01% | 2837 |
|
|
2021
Q3 | $3.42M | Sell |
122,860
-26,824
| -18% | -$747K | ﹤0.01% | 2685 |
|
|
2021
Q2 | $4.44M | Buy |
+149,684
| New | +$4.44M | ﹤0.01% | 2649 |
|
|
2021
Q1 | – | Sell |
-487,436
| Closed | -$13.8M | – | 3425 |
|
|
2020
Q4 | $13.8M | Sell |
487,436
-143,779
| -23% | -$4.07M | 0.01% | 2149 |
|
|
2020
Q3 | $15.9M | Sell |
631,215
-8,646
| -1% | -$217K | 0.01% | 1969 |
|
|
2020
Q2 | $15.6M | Buy |
639,861
+48,098
| +8% | +$1.17M | 0.01% | 1992 |
|
|
2020
Q1 | $8.76M | Sell |
591,763
-1,901
| -0.3% | -$28.1K | ﹤0.01% | 2184 |
|
|
2019
Q4 | $9.64M | Buy |
593,664
+121,018
| +26% | +$1.96M | ﹤0.01% | 2364 |
|
|
2019
Q3 | $6.15M | Buy |
472,646
+82,318
| +21% | +$1.07M | ﹤0.01% | 2532 |
|
|
2019
Q2 | $5.06M | Buy |
390,328
+16,424
| +4% | +$213K | ﹤0.01% | 2633 |
|
|
2019
Q1 | $5.89M | Buy |
373,904
+148,196
| +66% | +$2.34M | ﹤0.01% | 2592 |
|
|
2018
Q4 | $4.54M | Buy |
225,708
+149,952
| +198% | +$3.02M | ﹤0.01% | 2639 |
|
|
2018
Q3 | $1.88M | Buy |
+75,756
| New | +$1.88M | ﹤0.01% | 2941 |
|